80 FR 63791 - Meeting: Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 80, Issue 203 (October 21, 2015)
Centers for Disease Control and Prevention
Federal Register Volume 80, Issue 203 (October 21, 2015)
| Page Range | 63791-63792 | |
| FR Document | 2015-26757 |
[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)] [Notices] [Pages 63791-63792] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-26757] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting: Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:15 a.m.-5 p.m., Pacific Time, November 18, 2015. 8:15 a.m.-4:30 p.m., Pacific Time, November 19, 2015. Public Comment Time and Date: 5 p.m.-6 p.m.*, Pacific Time, November 18, 2015. * Please note that the public comment period ends at the time indicated above or following the last call for comments, whichever is earlier. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Place: Waterfront Hotel, 10 Washington Street, Oakland, California 94607, Phone: 510-379-2652; Fax: 510-832-6228. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1-866-659- 0537 with a pass code of 9933701. Live Meeting CONNECTION: https://www.livemeeting.com/cc/cdc/join?id GS59T7&role=attend&pw=ABRWH; Meeting ID: GS59T7; Entry Code: ABRWH. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 100 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2017. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters For Discussion: The agenda for the Advisory Board meeting [[Page 63792]] includes: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; Report by the Dose Reconstruction Review Methods Work Group; SEC Petitions Update; Site Profile reviews for: Dow Chemical Co. (Madison, Illinois), and General Steel Industries (Granite City, Illinois); SEC petitions for: Battelle Laboratories, King Avenue (1956-1970; Columbus, Ohio), Lawrence Livermore National Laboratory (1974-1995; Livermore, California), Blockson Chemical Co. (1960-1991; Joliet, Illinois), Rocky Flats Plant (1984-1989; Golden, Colorado), Idaho National Laboratory (1949-1970; Scoville, Idaho), and Kansas City Plant (1949-1993; Kansas City, Missouri); and Board Work Sessions. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted to the contact person well in advance of the meeting. Any written comments received will be provided at the meeting in accordance with the redaction policy provided below. Policy on Redaction of Board Meeting Transcripts (Public Comment): (1) If a person making a comment gives his or her personal information, no attempt will be made to redact the name; however, NIOSH will redact other personally identifiable information, such as contact information, social security numbers, case numbers, etc., of the commenter. (2) If an individual in making a statement reveals personal information (e.g., medical or employment information) about themselves that information will not usually be redacted. The NIOSH Freedom of Information Act (FOIA) coordinator will, however, review such revelations in accordance with the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (3) If a commenter reveals personal information concerning a living third party, that information will be reviewed by the NIOSH FOIA coordinator, and upon determination, if deemed appropriated, such information will be redacted, unless the disclosure is made by the third party's authorized representative under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) program. (4) In general, information concerning a deceased third party may be disclosed; however, such information will be redacted if (a) the disclosure is made by an individual other than the survivor claimant, a parent, spouse, or child, or the authorized representative of the deceased third party; (b) if it is unclear whether the third party is living or deceased; or (c) the information is unrelated or irrelevant to the purpose of the disclosure. The Board will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comments; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. Contact Person For More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, email: [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015-26757 Filed 10-20-15; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices 63791
staffing, and administrative support information (e.g., medical information) Place: Waterfront Hotel, 10
services for the Advisory Committee. about themselves, that information will Washington Street, Oakland, California
The charter was reissued on May 12, not usually be redacted. The CDC 94607, Phone: 510–379–2652; Fax: 510–
2015, and will expire on May 12, 2017. Freedom of Information Act coordinator 832–6228. Audio Conference Call via
Matters for Discussion: The Advisory will, however, review such revelations FTS Conferencing. The USA toll-free,
Committee will continue its in accordance with the Freedom of dial-in number is 1–866–659–0537 with
deliberations from the meeting on June Information Act and, if deemed a pass code of 9933701. Live Meeting
4, 2015, addressing the need for appropriate, will redact such CONNECTION: https://
research on developmental or health information. Disclosures of information www.livemeeting.com/cc/cdc/join?id
effects in children. The agenda will concerning third party medical GS59T7&role=attend&pw=ABRWH;
include presentations on children’s information will be redacted. Meeting ID: GS59T7; Entry Code:
health research that has been conducted Contact Person for More Information: ABRWH.
related to exposures from the 9/11 Paul J. Middendorf, Ph.D., Designated Status: Open to the public, limited
terrorist attacks. Also, a panel of Federal Officer, NIOSH, CDC, 2400 only by the space available. The meeting
children’s researchers will discuss Century Parkway NE., Mail Stop E–20, space accommodates approximately 100
children’s research issues with the Atlanta, GA 30345, telephone 1 (888) people.
Advisory Committee. 982–4748; email: wtc-stac@cdc.gov. Background: The Advisory Board was
The agenda is subject to change as The Director, Management Analysis established under the Energy Employees
priorities dictate. and Services Office, has been delegated Occupational Illness Compensation
Public Comment Sign-up and the authority to sign Federal Register Program Act of 2000 to advise the
Submissions to the Docket: To sign up Notices pertaining to announcements of President on a variety of policy and
to provide public comments or to meetings and other committee technical functions required to
submit comments to the docket, send management activities, for both the implement and effectively manage the
information to the NIOSH Docket Office Centers for Disease Control and new compensation program. Key
by one of the following means: Prevention, and the Agency for Toxic functions of the Advisory Board include
Mail: NIOSH Docket Office, Robert A. Substances and Disease Registry. providing advice on the development of
Taft Laboratories, C–34, 1090 Tusculum probability of causation guidelines
Avenue, Cincinnati, Ohio 45226. Catherine Ramadei, which have been promulgated by the
Email: nioshdocket@cdc.gov. Acting Director, Management Analysis and Department of Health and Human
Telephone: (513) 533–8611. Services Office, Centers for Disease Control Services (HHS) as a final rule; advice on
In the event an individual cannot and Prevention. methods of dose reconstruction which
attend, written comments may be [FR Doc. 2015–26759 Filed 10–20–15; 8:45 am] have also been promulgated by HHS as
submitted. The comments should be BILLING CODE 4163–18–P a final rule; advice on the scientific
limited to two pages and submitted validity and quality of dose estimation
through http://www.regulations.gov by and reconstruction efforts being
November 27, 2015. Efforts will be made DEPARTMENT OF HEALTH AND performed for purposes of the
to provide the two-page written HUMAN SERVICES compensation program; and advice on
comments received by the deadline petitions to add classes of workers to the
below to the committee members before Centers for Disease Control and
Special Exposure Cohort (SEC).
the meeting. Comments in excess of two Prevention
In December 2000, the President
pages will be made publicly available at Meeting: Advisory Board on Radiation delegated responsibility for funding,
http://www.regulations.gov. To view and Worker Health (ABRWH or staffing, and operating the Advisory
background information and previous Advisory Board), National Institute for Board to HHS, which subsequently
submissions go to NIOSH docket Occupational Safety and Health delegated this authority to the CDC.
http://www.cdc.gov/niosh/docket/ (NIOSH) NIOSH implements this responsibility
archive/docket248.html , http:// for CDC. The charter was issued on
www.cdc.gov/niosh/docket/archive/ In accordance with section 10(a)(2) of August 3, 2001, renewed at appropriate
docket248–A.html, and http:// the Federal Advisory Committee Act intervals, and will expire on August 3,
www.cdc.gov/niosh/docket/archive/ (Pub. L. 92–463), and pursuant to the 2017.
docket248–B.html. requirements of 42 CFR 83.15(a), the Purpose: This Advisory Board is
Policy on Redaction of Committee Centers for Disease Control and charged with (a) providing advice to the
Meeting Transcripts (Public Comment): Prevention (CDC), announces the Secretary, HHS, on the development of
Transcripts will be prepared and posted following meeting of the guidelines under Executive Order
to http://www.regulations.gov within 60 aforementioned committee: 13179; (b) providing advice to the
days after the meeting. If a person Times and Dates: 8:15 a.m.–5 p.m., Secretary, HHS, on the scientific
making a comment gives his or her Pacific Time, November 18, 2015. 8:15 validity and quality of dose
name, no attempt will be made to redact a.m.–4:30 p.m., Pacific Time, November reconstruction efforts performed for this
that name. NIOSH will take reasonable 19, 2015. program; and (c) upon request by the
steps to ensure that individuals making Public Comment Time and Date: 5 Secretary, HHS, advising the Secretary
public comments are aware of the fact p.m.–6 p.m.*, Pacific Time, November on whether there is a class of employees
that their comments (including their 18, 2015. at any Department of Energy facility
name, if provided) will appear in a * Please note that the public comment who were exposed to radiation but for
tkelley on DSK3SPTVN1PROD with NOTICES
transcript of the meeting posted on a period ends at the time indicated above whom it is not feasible to estimate their
public Web site. Such reasonable steps or following the last call for comments, radiation dose, and on whether there is
include a statement read at the start of whichever is earlier. Members of the reasonable likelihood that such
the meeting stating that transcripts will public who wish to provide public radiation doses may have endangered
be posted and names of speakers will comments should plan to attend the the health of members of this class.
not be redacted. If individuals in public comment session at the start time Matters For Discussion: The agenda
making a statement reveal personal listed. for the Advisory Board meeting
VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1](https://thefederalregister.org/doc/80_FR_63994/page/1.svg)
![63792 Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices
includes: NIOSH Program Update; the authorized representative of the Times and Dates
Department of Labor Program Update; deceased third party; (b) if it is unclear 8:30 a.m.–5 p.m.., November 18, 2015.
Department of Energy Program Update; whether the third party is living or 8:30 a.m.–12 p.m., November 19,
Report by the Dose Reconstruction deceased; or (c) the information is 2015.
Review Methods Work Group; SEC unrelated or irrelevant to the purpose of Place: CDC, 2500 Century Center
Petitions Update; Site Profile reviews the disclosure. Boulevard, Rooms 1200/1201, Atlanta,
for: Dow Chemical Co. (Madison, The Board will take reasonable steps Georgia 30345.
Illinois), and General Steel Industries to ensure that individuals making Status: Open to the public, limited
(Granite City, Illinois); SEC petitions for: public comment are aware of the fact only by the space available. The meeting
Battelle Laboratories, King Avenue that their comments (including their room accommodates approximately 100
(1956–1970; Columbus, Ohio), name, if provided) will appear in a people. This meeting will also be
Lawrence Livermore National transcript of the meeting posted on a webcast, please see information below.
Laboratory (1974–1995; Livermore, public Web site. Such reasonable steps Purpose: This Committee is charged
California), Blockson Chemical Co. include: (a) A statement read at the start with providing scientific and technical
(1960–1991; Joliet, Illinois), Rocky Flats advice and guidance to the Secretary of
of each public comment period stating
Plant (1984–1989; Golden, Colorado), Health and Human Services (HHS); the
that transcripts will be posted and
Idaho National Laboratory (1949–1970; Assistant Secretary for Health; the
names of speakers will not be redacted;
Scoville, Idaho), and Kansas City Plant Director, Centers for Disease Control
(b) A printed copy of the statement
(1949–1993; Kansas City, Missouri); and
mentioned in (a) above will be and Prevention; the Commissioner,
Board Work Sessions.
displayed on the table where Food and Drug Administration (FDA);
The agenda is subject to change as
priorities dictate. individuals sign up to make public and the Administrator, Centers for
In the event an individual cannot comments; (c) A statement such as Medicare and Medicaid Services (CMS).
attend, written comments may be outlined in (a) above will also appear The advice and guidance pertain to
submitted to the contact person well in with the agenda for a Board Meeting general issues related to improvement in
advance of the meeting. Any written when it is posted on the NIOSH Web clinical laboratory quality and
comments received will be provided at site; (d) A statement such as in (a) above laboratory medicine practice and
the meeting in accordance with the will appear in the Federal Register specific questions related to possible
redaction policy provided below. Notice that announces Board and revision of the Clinical Laboratory
Policy on Redaction of Board Meeting Subcommittee meetings. Improvement Amendment (CLIA)
Transcripts (Public Comment): (1) If a Contact Person For More Information: standards. Examples include providing
person making a comment gives his or Theodore Katz, Designated Federal guidance on studies designed to
her personal information, no attempt Officer, NIOSH, CDC, 1600 Clifton Road improve safety, effectiveness, efficiency,
will be made to redact the name; NE., MS E–20, Atlanta, Georgia 30333, timeliness, equity, and patient-
however, NIOSH will redact other telephone: (513) 533–6800, toll free: 1– centeredness of laboratory services;
personally identifiable information, 800–CDC–INFO, email: dcas@cdc.gov. revisions to the standards under which
such as contact information, social clinical laboratories are regulated; the
The Director, Management Analysis impact of proposed revisions to the
security numbers, case numbers, etc., of
and Services Office, has been delegated standards on medical and laboratory
the commenter.
(2) If an individual in making a the authority to sign Federal Register practice; and the modification of the
statement reveals personal information Notices pertaining to announcements of standards and provision of non-
(e.g., medical or employment meetings and other committee regulatory guidelines to accommodate
information) about themselves that management activities, for both the technological advances, such as new
information will not usually be Centers for Disease Control and test methods and the electronic
redacted. The NIOSH Freedom of Prevention and the Agency for Toxic transmission of laboratory information.
Information Act (FOIA) coordinator Substances and Disease Registry. Matters for Discussion: The agenda
will, however, review such revelations Catherine Ramadei, will include agency updates from CDC,
in accordance with the Federal Acting Director, Management Analysis and
CMS, and FDA. Presentations and
Advisory Committee Act and if deemed Services Office, Centers for Disease Control discussions will include laboratory
appropriate, will redact such and Prevention. information exchange (interoperability);
information. [FR Doc. 2015–26757 Filed 10–20–15; 8:45 am] noninvasive prenatal testing; CLIA
(3) If a commenter reveals personal waiver guidance; the Institute of
BILLING CODE 4163–18–P
information concerning a living third Medicine (IOM) report ‘‘Improving
party, that information will be reviewed Diagnosis in Health Care;’’ and FDA
by the NIOSH FOIA coordinator, and DEPARTMENT OF HEALTH AND guidance for laboratory developed tests.
upon determination, if deemed HUMAN SERVICES Agenda items are subject to change as
appropriated, such information will be priorities dictate.
redacted, unless the disclosure is made Centers for Disease Control and Webcast: The meeting will also be
by the third party’s authorized Prevention webcast. Persons interested in viewing
representative under the Energy the webcast can access information at:
Employees Occupational Illness Meeting: Clinical Laboratory http://
Compensation Program Act (EEOICPA) Improvement Advisory Committee cdclabtraining.adobeconnect.com/
tkelley on DSK3SPTVN1PROD with NOTICES
program. novcliac/.
(4) In general, information concerning In accordance with section 10(a)(2) of Online Registration Required: All
a deceased third party may be disclosed; the Federal Advisory Committee Act people attending the CLIAC meeting in-
however, such information will be (Pub. L. 92–463), the Centers for Disease person are required to register for the
redacted if (a) the disclosure is made by Control and Prevention (CDC) meeting online at least 5 business days
an individual other than the survivor announces the following committee in advance for U.S. citizens and at least
claimant, a parent, spouse, or child, or meeting. 10 business days in advance for
VerDate Sep<11>2014 22:39 Oct 20, 2015 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1](https://thefederalregister.org/doc/80_FR_63994/page/2.svg)
Document Created: 2018-02-27 08:54:13
Document Modified: 2018-02-27 08:54:13
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 8:15 a.m.-5 p.m., Pacific Time, November 18, 2015. 8:15 a.m.-4:30 p.m., Pacific Time, November 19, 2015. | |
| FR Citation | 80 FR 63791 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR